ABT (Abbott Laboratories) Inventories, Finished Goods: $4,274 Mil (As of Mar. 2026)


ABT Abbott Laboratories ABT
80 GF Score
Price $95.40
GF Value $129.98
Valuation Modestly Undervalued
View Full Analysis

What is Abbott Laboratories Inventories, Finished Goods?

Abbott Laboratories ABT +3.49% 80 Inventories, Finished Goods is $4,274 Mil as of Mar. 2026. GuruFocus rates ABT with a GF Score™ of 80/100 and a GF Value™ of $129.98 (Modestly Undervalued).

Abbott Laboratories's quarterly finished goods declined from Sep. 2025 ($4,130 Mil) to Dec. 2025 ($3,976 Mil) but then increased from Dec. 2025 ($3,976 Mil) to Mar. 2026 ($4,274 Mil).

Abbott Laboratories's annual finished goods declined from Dec. 2023 ($3,946 Mil) to Dec. 2024 ($3,700 Mil) but then increased from Dec. 2024 ($3,700 Mil) to Dec. 2025 ($3,976 Mil).


Abbott Laboratories Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Inventories, Finished Goods Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,081.00 3,805.00 3,946.00 3,700.00 3,976.00

Abbott Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,063.00 4,319.00 4,130.00 3,976.00 4,274.00
ABT
80GF Score
Abbott Laboratories ABT
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of $4,274 Mil mean?
Abbott Laboratories (ABT) has a Inventories, Finished Goods of $4,274 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Abbott Laboratories and its competitors.
Is Abbott Laboratories' Inventories, Finished Goods too high?
Abbott Laboratories' current Inventories, Finished Goods is $4,274 Mil. Overall, Abbott Laboratories has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Inventories, Finished Goods compare to SYK and MDT?
Abbott Laboratories' Inventories, Finished Goods of $4,274 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Medical Devices & Instruments company?
A good Inventories, Finished Goods depends on the Medical Devices & Instruments industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Abbott Laboratories and its competitors. Abbott Laboratories's current Inventories, Finished Goods is $4,274 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (ABT) is currently considered Modestly Undervalued. The stock's GF Value™ is $129.98, compared to a current price of $95.40 — trading 26.6% below its estimated fair value. The current Inventories, Finished Goods is $4,274 Mil. Abbott Laboratories' overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Abbott Laboratories (ABT), the current Inventories, Finished Goods is $4,274 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of $95.40 is trading 26.6% below its estimated GF Value™ of $129.98. GuruFocus considers Abbott Laboratories to be Modestly Undervalued.

Key valuation signals for ABT:

  • Inventories, Finished Goods: $4,274 Mil
  • GF Value™: $129.98 vs. price of $95.40 (26.6% below fair value)
  • GF Score™: 80/100

No single metric tells the full story. See the ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score

Get the complete analysis for ABT

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$95.40
Price
$129.98
GF Value